Navigation Links
Alex Galindo, Attorney and Partner at Curd, Galindo & Smith, LLP, Court Wins Against the County of Riverside's Motion to Dismiss Medical Malpractice Case

Riverside, California (PRWEB) June 18, 2012

In the lawsuit entitled Andrew Rodriguez v. County of Riverside Case No.:RIC 10019122, court records show that Judge Ottalia denied the County's recent motion to have the case dismissed and the case was set for a jury trial to commence January 25, 2013.

The filed complaint alleges that Mr. Rodriguez who is represented by attorney Alex Galindo with the Long Beach, California firm, Curd, Galindo & Smith, LLP, had a liver transplant in 2000 at USC University Hospital. Since that time, he has been under the care of a liver team at USC University Hospital headed by Dr. Fong.

The lawsuit states that Mr. Rodriguez first presented for care and treatment to the County of Riverside in 2008. In 2008, Mr. Rodriguez had uncontrolled insulin-dependent diabetes, which was an issue to be managed by the County’s Community Health clinic. Mr. Rodriguez was prescribed Lipitor 10mg in 2006. Lipitor is a satin medication, which is used to lower blood cholesterol levels by inhibiting a liver enzyme necessary to produce cholesterol. It also prevents heart attacks and strokes.

The complaint further states that Bruce Grundl a physician's assistant at the County of Riverside reviewed Mr. Rodriguez’s Lipid panel results from the June 10, 2009 testing. Mr. Rodriguez was called to schedule an appointment to the county’s medical clinic set for June 24, 2009.

Mr. Rodriguez alleges in his lawsuit that when he presented to the County’s internal medicine clinic June 24, 2009, he was suffering from metabolic syndrome, a combination of medical disorders that include high blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol levels. When these medical disorders are grouped together, they increase a patient’s risk of developing heart disease, stroke, and diabetes. On this day, Mr. Rodriguez was seen by physician’s assistant Bruce Grundl, who reviewed labs with Mr. Rodriguez and prescribed an increase in his Zocor (generic: Simvastatin) medication from 20 milligrams to 80 milligrams, in order to address the high cholesterol and triglycerides. PA Grundl wrote a prescription for Zocor 80mg, 30 tablets, to take once a day in the evening.

Bruce Grundl, P.A. was supervised by Dr. Moffatt and Mr. Grundl failed to consult with Dr. Moffatt or any other physician before increasing the Zocor from 20 mg to 80 mg.

On July 14, 2009, Mr. Rodriguez was admitted to Eisenhower for treatment of a urinary tract infection and renal failure. The consulting nephrologist suspected the renal dysfunction could be due to cyclosporine neohrotoxicity.

On August 27, 2009, Mr. Rodriguez presented to the Eisenhower Medical Center for generalized weakness. He was transferred to U.S.C. Hospital, where he was diagnosed with acute renal failure and rhabdomyolysis (muscle breakdown). He was treated and discharged on September 9, 2009 in good condition. Mr. Rodriguez’s hospitalization at USC University Hospital was for renal failure due to an increase in Zocor.

Mr. Rodriguez, as a liver transplant patient had a liver team at USC, which should have been consulted by Mr. Grundl before increasing the Zocor. Mr. Rodriguez asked Mr. Grundl to contact the liver team, however, he never did. Due to Mr. Rodriguez’s chronic liver and kidney conditions and medication prescribed should have been carefully analyzed. The court documents show that Mr. Rodriguez’s liver team physician, Dr. Javadi testified in deposition that she would not have authorized an increase of Zocor from 20 mg to 80 mg.

Mr. Rodriguez alleges in the lawsuit that as a result of the prescribed increase in Zocor from 20 mg to 80 mg, Plaintiff suffered extreme pain and muscle weakness and was hospitalized at two different facilities.

Mr. Rodriguez has demanded compensatory damages and the County has denied any liability.

Keep up with this and other cases of Curd, Galindo & Smith, LLP, LLP on Facebook.

CURD, GALINDO & SMITH, LLP is a civil business litigation firm that represents both corporate and professional clients of all sizes and those who have been seriously injured or have lost a family member due to an accident, defective product, police misconduct or negligence. The law firm has recovered millions of dollars for its thousands of clients since 1995 by winning complex and challenging business disputes, death and injury cases involving police misconduct, traffic collisions, work place injuries and defective products, including defective automobiles, against some of the world's largest companies and governmental agencies.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved  

Related medicine news :

1. US Drug Watchdog Launches Now Calls Transvaginal Mesh A Disaster For 100,000's of US Women Recipients And Offers The Names and Contacts Of The Best Women Attorneys
2. US Drug Watchdog Now Urges All Recalled DePuy ASR Hip Implant Recipients Call Them For The Names Of The Best Attorneys Out Of Fear The Recipients Will Get Nothing
3. ACP-New York State Chapter partnership results in patient safety organization recognition
4. Cyber exercise partners help you go the distance
5. FDA clears test developed in partnership with VCU researcher
6. Global Cassava Partnership for the 21st Century (GCP21)
7. Partnership provides inclusive workout
8. University of Houston Graduate College of Social Work announces partnership with MD Anderson
9. Women With Older Partners More Often Admitted to Nursing Homes
10. The Tennessee Car Accident Lawyers at Michael D. Ponce & Associates Alert Public of CDC Survey Revealing Majority of High School Seniors Admitting to Texting Behind Wheel
11. Beef & Pork Wholesaling in the US Industry Market Research Report Now Available from IBISWorld
Post Your Comments:
Related Image:
Alex Galindo, Attorney and Partner at Curd, Galindo & Smith, LLP, Court Wins Against the County of Riverside's Motion to Dismiss Medical Malpractice Case
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution is underway. ... transport experience for the millions of people who require these medical transport services ... industry through the use of technology. Now, SmartEMS has put forth an industry-changing ...
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer ... they remain in the eye of the beholder, according to experts who offered insights ... American Journal of Managed Care. For the full issue, click here . , ...
(Date:6/26/2016)... ... 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing ... their videos a whole new perspective by using the title layers in ProSlice ... , ProSlice Levels contains over 30 Different presets to choose from. FCPX ...
(Date:6/26/2016)... ... 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop ... The fitness app plans to fix the two major problems leading the fitness industry today:, ... all type program , They don’t eliminate all the reasons people quit their ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
(Date:6/24/2016)... , June 24, 2016 According ... by Type (Standard Pen Needles, Safety Pen Needles), Needle ... GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) - ... This report studies the market for the forecast period ... reach USD 2.81 Billion by 2021 from USD 1.65 ...
Breaking Medicine Technology: